Mount Sinai’s J Mocco, MD, to Lead the Society of NeuroInterventional Surgery
J Mocco, MD, MS, Senior Vice Chair, Director of the Cerebrovascular Center, and Co-Director of the Neuroendovascular Surgery Fellowship Program in the Department of Neurosurgery at Mount Sinai, has been named president-elect of the Society of NeuroInterventional Surgery (SNIS), a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery, effective July 29, 2021. With more than 600 members worldwide, the organization’s mission is to promote the highest quality, comprehensive, minimally-invasive care for patients with stroke, brain aneurysms, and other diseases of the head, neck and spine.
Dr. Mocco is an internationally recognized cerebrovascular and endovascular neurosurgeon, with clinical interests in stroke, brain aneurysms, subarachnoid hemorrhage, arteriovenous malformations, cavernous malformations, and carotid artery stenosis. His research interests focus on translational efforts to treat ischemic and hemorrhagic stroke. He has published more than 525 peer-reviewed publications, edited three textbooks on neurosurgical techniques, and runs numerous national and international clinical trials to improve the treatment of patients with cerebrovascular disease.
“An internationally acclaimed neurosurgeon known for tirelessly advancing science to attain the highest quality of care for patients with cerebrovascular diseases, Dr. Mocco strives to globally transform the field of endovascular neurosurgery through his innovative ideas, novel administrative strategies, groundbreaking research, and inspiring leadership. A mentor and educator for neurosurgery residents and fellows, Dr. Mocco is dedicated to expanding the boundaries of conventional practice to help improve the lives of patients around the world,” said Joshua B. Bederson, MD, Chair of Neurosurgery at Mount Sinai Health System. “We are delighted that the Society of NeuroInterventional Surgery has chosen him as president-elect. This role will further enable Dr. Mocco to share his visionary leadership with people around the world who study and treat these conditions.”
Dr. Mocco received his medical degree from Columbia University College of Physicians and Surgeons. He earned a Master of Science degree in Biostatistics from the Mailman School of Public Health at Columbia University, did his residency in neurological surgery at the Neurological Institute of New York, and completed a fellowship in endovascular neurosurgery from the University at Buffalo. Prior to joining the Icahn School of Medicine at Mount Sinai in 2014, Dr. Mocco held clinical and academic positions at the University of Buffalo, the University of Florida, and Vanderbilt University Medical Center.
Dr. Mocco has been a principal investigator of more than two dozen research trials and is the recipient of numerous honors and awards in his field. He is the first person to serve as President-elect of the Society for NeuroInterventional Surgery and as Chair of the Cerebrovascular Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.
Dr. Mocco will assume the presidency in July 2022.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.